13 sept. 2026•3 min de lecture
Health Insurance Covers Duochem Bio's PSMA PET-CT Test for Prostate Cancer
Duochem Bio's PSMA-targeted PET-CT radiopharmaceutical ‘Prostasic’ is now reimbursed under South Korea’s health insurance, lowering costs for patients with moderate‑to‑high metastasis risk.